It is typically administered by a healthcare professional in a clinic or hospital, but in some situations, patients may need to administer this medication in the home environment
Acta Medica Scandinavica, 184: 247258
Just this year, the FDA approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia caused by chronic kidney disease, for adults who have been receiving dialysis for at least four months
The 75mg dose should be administered via subcutaneous injection each morning, approximately 30 minutes before the first meal of the day
Last reviewed: June 12, 2026 Last updated: June 12, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations